PLSE - Pulse Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
22,296
17,253
9,646
5,988
2,578
Selling General and Administrative
19,037
20,045
15,503
2,933
1,224
Total Operating Expenses
41,998
37,963
25,814
9,586
4,468
Operating Income or Loss
-41,998
-37,963
-25,814
-9,586
-4,468
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
-28
-665
0
0
Income Before Tax
-41,151
-37,545
-25,567
-9,518
-4,468
Income Tax Expense
-
0
0
0
-1,657
Income from Continuing Operations
-41,151
-37,545
-25,567
-9,518
-2,811
Net Income
-41,151
-37,545
-25,567
-9,518
-2,811
Net Income available to common shareholders
-41,151
-37,545
-25,567
-9,518
-2,811
Reported EPS
Basic
-
-2.20
-1.73
-0.86
-0.37
Diluted
-
-2.20
-1.73
-0.86
-0.37
Weighted average shares outstanding
Basic
-
17,078
14,754
11,009
7,565
Diluted
-
17,078
14,754
11,009
7,565
EBITDA
-
-36,653
-24,813
-8,827
-3,751